SCHEMBL3897247

SCHEMBL3897247

O=S(=O)(O)C=Cc1c2c(nn1Cc1ccccc1)CCSC2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
ALDH1A1 P00352 5/20 0.33
LMNA P02545 2/20 0.33
PTGS1 P23219 1/20 0.33
MAPT P10636 3/20 0.32
HPGD P15428 2/20 0.32
KDM4E B2RXH2 1/20 0.32
PARP1 P09874 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
AADAT Q8N5Z0 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
POLB P06746 1/20 0.31
PDK1 Q15118 1/20 0.31
TSHR P16473 1/20 0.31
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3897246 1.00 HTR2C (0.35) HTR2CHTR2BMEN1KMT2AALDH1A1
SCHEMBL3890965 0.82 HTR2C (0.40) HTR2CHTR2BMEN1KMT2AALDH1A1
SCHEMBL3889267 0.81 HDAC10 (0.35) HTR2CHTR2BMEN1KMT2AALDH1A1
SCHEMBL3889272 0.81 HDAC10 (0.35) HTR2CHTR2BMEN1KMT2AALDH1A1
SCHEMBL13866932 0.81 CNR2 (0.39) HTR2CHTR2BALDH1A1RAB9APOLB
SCHEMBL13866925 0.81 CNR2 (0.39) HTR2CHTR2BALDH1A1RAB9APOLB
SCHEMBL4711770 0.79 HTR2C (0.34) HTR2CHTR2BMEN1KMT2AALDH1A1
SCHEMBL4709012 0.78 MEN1 (0.34) HTR2CHTR2BMEN1KMT2AALDH1A1
SCHEMBL13866935 0.78 EPHX2 (0.34) ALDH1A1TSHR
SCHEMBL13867220 0.70 PDE4A (0.36) HTR2CHTR2BMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7524964-B2 Tetrahydrothiopyrano pyrazole cannabinoid modulators JANSSEN PHARMACEUTICA NV (BE) 2009-04-28 US disclosed
EP-1863479-B1 TETRAHYDROTHIOPYRANO PYRAZOLE CANNABINOID MODULATORS CROSS REFERENCE TO RELATED APPLICATIONS JANSSEN PHARMACEUTICA NV (BE) 2008-12-10 EP disclosed
US-20080085899-A1 TETRAHYDROTHIOPYRANO PYRAZOLE CANNABINOID MODULATORS LIOTTA FINA 2008-04-10 US disclosed
US-20060223798-A1 Tetrahydrothiopyrano pyrazole cannabinoid modulators JANSSEN PHARMACEUTICA NV (BE) 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223798-A1 Tetrahydrothiopyrano pyrazole cannabinoid modulators CNR1, CNR2, GPR18 HTR2C 19/4885HTR2B 189/4885MEN1 4352/4885
US-20080085899-A1 TETRAHYDROTHIOPYRANO PYRAZOLE CANNABINOID MODULATORS CNR1, CNR2, GPR18 HTR2C 19/4885HTR2B 189/4885MEN1 4352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.